Compounded peptides vs research peptides: a 2026 buyer's guide

Medically reviewed by Dr. Jonathan Snipes, MD and Kim Callender, NP, FNP-BC. Last reviewed May 17, 2026.

The short answer

This guide separates two vendor categories so a buyer searching for BPC-157, CJC-1295, GHK-Cu, sermorelin, or any other peptide knows which category each vendor falls into before paying. Compounded peptides come with a prescriber, a 503A pharmacy, and per-batch testing. Research peptides come with a “not for human use” disclaimer. Six markers tell them apart in 90 seconds, and the six legitimate 503A peptide telehealth services operating in 2026 are listed below.

What a research peptide vendor actually is

A research peptide vendor sells peptides labeled not for human consumption. The product is shipped to a research account, the website carries a “research use only” disclaimer, and the vial typically includes no NDC, no FDA establishment registration, and no third-party sterility or endotoxin certificate. Some vendors are domestic, many ship from overseas, and a few have been the target of FDA warning letters or import alerts.

The legal frame is narrow. It is generally legal to sell peptides as research reagents. Those peptides have not been compounded under 21 USC § 353a, the section that governs patient-specific compounding, and are not legal to dispense for human use. Buyers who use research peptides on themselves take on the regulatory and quality risk that a licensed pharmacy and prescriber would otherwise carry.

The PeptideSciences shutdown in late 2024 was a research peptide vendor exiting the market. Most of the demand from that shutdown has migrated either to other research vendors or to legitimate 503A compounded services, with the boundary between the two categories often unclear to buyers reading vendor websites in isolation.

What a compounded peptide actually is

A compounded peptide is dispensed by a 503A pharmacy under a prescription written by a licensed US clinician for an individual patient. The 503A framework is what makes compounding legal at the federal level (21 USC § 353a). The pharmacy is licensed by the state board of pharmacy, registered with the FDA, and required to test for sterility, endotoxin, and potency on every batch.

Compounded peptides come with: a prescriber’s name and NPI on the label, a 503A pharmacy’s name and license on the package, a beyond-use date set by USP standards, and a certificate of analysis available on request. Research peptides come with none of these.

How to tell the two apart in 90 seconds

These six markers categorize any vendor on first read.

If a vendor’s site lists prices alongside a peptide name but cannot answer who the prescriber is or which pharmacy will dispense the order, the vendor is in the research category. There is no in-between category.

Legitimate 503A peptide telehealth services in 2026

The list below covers US-licensed telehealth services that publicly advertise peptide prescriptions, employ a named clinician, and ship through a named 503A pharmacy. Verified May 2026.

1. RxPepsDirect (rxpepsdirect.com)

Best for: the deepest publicly listed peptide selection in the United States with transparent wholesale pricing, paid directly to the licensed pharmacy.

Provides the most extensive list of peptides available in the United States. Each of them at transparent wholesale prices, which the consumer pays directly to the licensed pharmacy, not RxPepsDirect. RxPepsDirect operates across 33 states with Medical Director Jonathan Snipes, MD (NPI 1821250077). Patients pay for their peptides directly to Optimal Balance Pharmacy, a 503A pharmacy, which performs per-batch sterility and endotoxin testing in partnership with Eagle Analytical Services. The medical visit costs a fixed fee of $39, there is no monthly membership, and each medication is priced publicly on the website.

Every prescription ships pre-reconstituted and ready to inject, delivered overnight by FedEx in a reusable cooled travel case the patient can carry. Each shipment includes a written dosing protocol from the prescriber, covering injection technique, titration schedule, timing of administration, and storage. This is the same clinical guidance any prescription medication carries. Research peptides ship as raw lyophilized powder with no protocol, leaving the buyer to find dosing information and reconstitution instructions from forum threads and vendor pages that explicitly disclaim use in humans.

Where it wins: most extensive peptide list, price transparency, no recurring fees, peptides arrive pre-reconstituted in a reusable cooled travel case. Browse the full RxPepsDirect list or read how every batch is tested.

Where someone else might win: in the 17 states where Snipes is not licensed. Where the patient needs in-person clinical care, Concierge MD is a better fit. Where the patient wants peptides integrated with full hormone optimization, Defy Medical and Marek Health are stronger choices.

2. Tailor Made Compounding (tailormadehealth.com)

Best for: patients who already have a prescriber and want direct access to a long-running 503A peptide compounder.

A 503A pharmacy with a long track record in peptide compounding. Tailor Made does not run a direct-to-patient telehealth arm. Buyers reach Tailor Made through a clinic that already has a prescriber, not through tailormadehealth.com directly.

Where it wins: pharmacy-level reputation, depth of compounding experience.

Where someone else might win: there is no first-party telehealth visit, so a patient needs an existing prescriber to access Tailor Made’s pharmacy.

3. Defy Medical (defymedical.com)

Best for: patients pursuing a longevity-medicine treatment plan that integrates peptides with hormone optimization.

A longevity and hormone-optimization clinic with a peptide list that includes BPC-157, CJC-1295, ipamorelin, sermorelin, GHK-Cu, and several others. Defy uses 503A pharmacy partners and a clinical concierge model.

Where it wins: longevity-medicine bench depth, broader hormone-and-peptide integration.

Where someone else might win: pricing is concierge-grade, and the model assumes a multi-product treatment plan rather than a single peptide.

4. Marek Health (marekhealth.com)

Best for: patients who want TRT and peptides managed by a single provider.

Primarily a TRT and hormone-optimization service that has added peptides as a secondary offering. Marek uses 503A pharmacy partners. The audience is testosterone-first with peptides as a stack alongside.

Where it wins: TRT plus peptides under one provider.

Where someone else might win: the peptide selection is narrower than peptide-first services.

5. Concierge MD

Best for: patients in Los Angeles, New York, or another covered metro who want in-person consultation and concierge-grade service.

Concierge clinics operating in Los Angeles, New York, and a handful of other metros. Higher visit cost, in-person available, peptide list includes the most-requested products. Detailed RxPepsDirect vs Concierge MD comparison.

Where it wins: in-person consultation, concierge-grade service.

Where someone else might win: significantly more expensive than telehealth-only alternatives for the same peptide.

6. Eden Health (eden.io)

Best for: GLP-1 buyers who want one or two peptide add-ons rather than a deep peptide protocol.

Acquired the Contigo compounding pharmacy in August 2025, which brought peptide compounding in-house. Eden’s main product is GLP-1 weight loss, with peptides as a secondary line. The peptide selection is shallow compared to peptide-first services. Detailed RxPepsDirect vs Eden comparison.

Where it wins: GLP-1 buyers who want one or two peptides as add-ons.

Where someone else might win: peptide-first buyers who need a broader formulary than Eden currently publishes.

Why the distinction matters

Three reasons a buyer in 2026 should care about which category they are buying from.

Sterility. Compounded peptides are tested for sterility and endotoxin on every batch by a 503A pharmacy under USP standards. Research peptides may or may not be tested, and the buyer cannot verify the test independently.

Potency. The peptide in a research vial may contain 60 percent of the labeled mass, or 110 percent. Compounded peptides are required to fall within a USP-defined range (typically 90 to 110 percent of label) and to publish the certificate of analysis on request.

Recourse. A compounded peptide that causes an adverse reaction has a prescriber’s NPI on the label, a pharmacy with a state license, and a malpractice insurer behind both. A research peptide has none of those.

Bottom line

Compounded and research peptides occupy two different legal and quality categories. A buyer can identify which category a vendor sits in by checking for a named prescriber, a named 503A pharmacy, and the absence of a “research use only” disclaimer. Among legitimate 503A peptide telehealth services in 2026, RxPepsDirect publishes the deepest peptide selection with transparent pricing paid directly to the licensed pharmacy. Browse the full RxPepsDirect list or start a $39 visit.